Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 16,700 KRW
Change Today -300.00 / -1.76%
Volume 319.2K
As of 2:12 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for daehwa pharm co ltd (067080)

Year over year, DAE HWA Pharmaceutical Co., Ltd. has seen their bottom line shrink from a gain of 1.7B KRW to a loss of 102.0M KRW despite an increase in revenues from 128.0B KRW to 134.9B KRW. An increase in the percentage of sales devoted to income tax expenses from 1.02% to 4.80% was a key component in the falling bottom line in the face of rising revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of South Korean Wons
As of:Dec 31
2011
KRW
Dec 31
2012
KRW
Dec 31
2013
KRW
Dec 31
2014
KRW
4 Year
Trend
Revenues142,037.4143,167.7127,997.9134,930.6
Other Revenues----0.0--
TOTAL REVENUES142,037.4143,167.7127,997.9134,930.6
Cost of Goods Sold105,771.0107,241.195,650.695,768.1
GROSS PROFIT36,266.435,926.732,347.339,162.6
Selling General & Admin Expenses, Total25,908.225,261.024,774.030,365.8
R&D Expenses972.91,926.32,325.63,732.5
Depreciation & Amortization, Total362.3492.3510.3449.6
Other Operating Expenses170.2150.5177.7165.9
OTHER OPERATING EXPENSES, TOTAL27,413.627,830.127,787.734,713.9
OPERATING INCOME8,852.88,096.54,559.64,448.7
Interest Expense-2,598.2-2,553.8-1,706.4-1,420.5
Interest and Investment Income415.7376.0405.1389.2
NET INTEREST EXPENSE-2,182.5-2,177.8-1,301.3-1,031.4
Income (Loss) on Equity Investments52.9185.556.99.4
Currency Exchange Gains (Loss)18.9-6.7-49.422.4
Other Non-Operating Income (Expenses)-740.1-569.045.01,848.3
EBT, EXCLUDING UNUSUAL ITEMS6,001.95,528.63,310.75,297.3
Gain (Loss) on Sale of Investments---16.6----
Gain (Loss) on Sale of Assets5.00.325.533.2
EBT, INCLUDING UNUSUAL ITEMS6,007.05,512.33,336.25,330.5
Income Tax Expense2,246.51,957.71,311.36,478.3
Minority Interest in Earnings-392.1-406.7-349.41,045.7
Earnings from Continuing Operations3,760.53,554.62,025.0-1,147.8
NET INCOME3,368.43,147.91,675.5-102.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS3,368.43,147.91,675.5-102.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS3,368.43,147.91,675.5-102.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
067080:KS 16,700.00 KRW -300.00

067080 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 067080.
View Industry Companies
 

Industry Analysis

067080

Industry Average

Valuation 067080 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.9x
Price/Book 4.5x
Price/Cash Flow 905.8x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAEHWA PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.